These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15173890)

  • 1. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells.
    Oki S; Chiba A; Yamamura T; Miyake S
    J Clin Invest; 2004 Jun; 113(11):1631-40. PubMed ID: 15173890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo.
    Oki S; Tomi C; Yamamura T; Miyake S
    Int Immunol; 2005 Dec; 17(12):1619-29. PubMed ID: 16291659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
    Miyamoto K; Miyake S; Yamamura T
    Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide.
    Chiba A; Oki S; Miyamoto K; Hashimoto H; Yamamura T; Miyake S
    Arthritis Rheum; 2004 Jan; 50(1):305-13. PubMed ID: 14730629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment for multiple sclerosis with a synthetic glycolipid].
    Miyamoto K
    Nihon Rinsho; 2003 Aug; 61(8):1442-8. PubMed ID: 12962036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.
    Miyake S; Yamamura T
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):315-22. PubMed ID: 16178791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM; Palmer JL; Gamelli RL; Faunce DE
    Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
    Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
    Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of natural killer T cells by glycolipids.
    Tupin E; Kronenberg M
    Methods Enzymol; 2006; 417():185-201. PubMed ID: 17132506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
    Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
    Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.
    Bessoles S; Fouret F; Dudal S; Besra GS; Sanchez F; Lafont V
    J Leukoc Biol; 2008 Jul; 84(1):224-33. PubMed ID: 18456817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.
    Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA
    J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K
    Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12.
    Matikainen S; Paananen A; Miettinen M; Kurimoto M; Timonen T; Julkunen I; Sareneva T
    Eur J Immunol; 2001 Jul; 31(7):2236-45. PubMed ID: 11449378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.
    Shang P; Zhang C; Xia C; Chen W; Han Q; Wang PG; Zhang J; Tian Z
    Int Immunopharmacol; 2008 May; 8(5):645-53. PubMed ID: 18387506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.